• TargetMol
    您的购物车当前为空

Anti-Palivizumab Antibody (9J81)

一键复制产品信息
Rating icon 还可以
货号 TMAS-00074

别名 Synagis

Anti-Palivizumab Antibody (9J81) 是一种 Mouse 抗体,靶向 Palivizumab。Anti-Palivizumab Antibody (9J81) 可用于 ELISA, Competitive ELISA。

Anti-Palivizumab Antibody (9J81)

Anti-Palivizumab Antibody (9J81)

一键复制产品信息
Rating icon 还可以
货号 TMAS-00074 别名 Synagis

Anti-Palivizumab Antibody (9J81) 是一种 Mouse 抗体,靶向 Palivizumab。Anti-Palivizumab Antibody (9J81) 可用于 ELISA, Competitive ELISA。

规格价格库存数量
40 μg
¥ 1,609
5日内发货
库存状态实时更新,以官网显示为准,现货产品可直接加购物车下单
大包装 & 定制
加入购物车
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
实验操作小课堂
常见问题解答
查看更多
资源下载:

产品介绍


生物活性
产品描述
Anti-Palivizumab Antibody (9J81) is a Mouse antibody targeting Palivizumab. Anti-Palivizumab Antibody (9J81) can be used in ELISA, Competitive ELISA.
别名Synagis
Ig Type
IgG1,κ
克隆号
9J81
特异性
Palivizumab
应用ELISACompetitive ELISA
推荐剂量
ELISA: 0.001-0.1 µg/ml; Competitive ELISA: 5-30 µg/ml
抗体种类
Monoclonal
宿主来源Mouse
纯化方式Protein A affinity column
性状Lyophilized. Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/ml.
缓冲液Lyophilized with PBS, pH 7.2, containing 0.02% sodium azide.
研究背景Palivizumab with trade name Synagis, is an FDA-approved drug for the prevention of respiratory syncytial virus (RSV) infections. It is a recombinant humanized IgG1 kappa isotype monoclonal antibody. Palivizumab binds the RSV envelope fusion protein (RSV F) on the surface of the virus and blocking a critical step in the membrane fusion process.
偶联与修饰
偶联
Unconjugated
抗原信息
免疫原
Palivizumab
储存&溶解度
储存方式The lyophilized product store at -20°C or -80°C for 12 months. The reconstituted antibody can be stored at 2°C-8°C for 2-3 weeks or at -20°C for 12 months. Avoid repeated freeze-thaw cycles.
运输方式Shipping with blue ice.
存储-20°C for 1 year

计算器

  • 稀释 计算器
Related Tags: buy Anti-Palivizumab Antibody (9J81) | purchase Anti-Palivizumab Antibody (9J81) | Anti-Palivizumab Antibody (9J81) cost | order Anti-Palivizumab Antibody (9J81)